IL17A and neoplasm: In the context of chronic cancer and inflammation, IL-17’s tumor-promoting activity—mainly through the enhancement of angiogenesis—often surpasses its anticancer functions, including the stimulation of cytotoxic T lymphocytes and other immune cells that target tumors.25,26